Authors: ELEFANT E SAINTECROIX A

Citation: E. Elefant et A. Saintecroix, EVALUATION OF DRUG RISK DURING PREGNANCY - METHODOLOGY AND RISK MANAGEMENT, Therapie, 52(4), 1997, pp. 307-312

Authors: MCELHATTON PR GARBIS HM ELEFANT E VIAL T BELLEMIN B MASTROIACOVO P ARNON J RODRIGUEZPINILLA E SCHAEFER C PEXIEDER T MERLOB P DALVERME S

Citation: Pr. Mcelhatton et al., THE OUTCOME OF PREGNANCY IN 689 WOMEN EXPOSED TO THERAPEUTIC DOSES OFANTIDEPRESSANTS - A COLLABORATIVE STUDY OF THE UROPEAN-NETWORK-OF-TERATOLOGY-INFORMATION-SERVICES (ENTIS), Reproductive toxicology, 10(4), 1996, pp. 285-294

Authors: ELEFANT E BIOUR B BLUMBERGTICK J ROUX C THOMAS F

Citation: E. Elefant et al., ADMINISTRATION OF A GONADOTROPIN-RELEASING-HORMONE AGONIST DURING PREGNANCY - FOLLOW-UP OF 28 PREGNANCIES EXPOSED TO TRIPTORELINE, Fertility and sterility, 63(5), 1995, pp. 1111-1113

Authors: GARBIS H ELEFANT E BERTOLOTTI E ROBERT E SERAFINI MA PRAPAS N

Citation: H. Garbis et al., PREGNANCY OUTCOME AFTER PERICONCEPTIONAL AND FIRST-TRIMESTER EXPOSURETO METHOXSALEN PHOTOCHEMOTHERAPY, Archives of dermatology, 131(4), 1995, pp. 492-493

Authors: VAILLANT L RIHOUX JP SESBOUE P SAINTSALVI MB ELEFANT E

Citation: L. Vaillant et al., PREGNANCY AND PRESCRIPTION OF ANTIHISTAMI NES, Annales de dermatologie et de venereologie, 121(10), 1994, pp. 773-775